Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review-Reference-Cited by-同舟云学术

Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review

Published:2015-10-17 Issue:1 Volume:15 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Remschmidt Cornelius,Wichmann Ole,Harder Thomas

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-015-1154-y.pdf

Reference39 articles.

1. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010:CD004876. doi: 10.1002/14651858 .

2. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7:658–66.

3. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35:337–44.

4. Hak E, Hoes AW, Nordin J, Nichol KL. Benefits of influenza vaccine in US elderly--appreciating issues of confounding bias and precision. Int J Epidemiol. 2006;35:800–2. author reply 799–800.

5. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case–control study. Lancet. 2008;372:398–405.

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population;American Journal of Ophthalmology;2025-01

2. Failure to address crucial biases other than the healthy vaccinee effect;International Journal of Infectious Diseases;2024-09

3. Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-09

4. No evidence that ACE2 or TMPRSS2 drive population disparity in COVID risks;BMC Medicine;2024-08-26

5. The effect of herpes zoster vaccination at different stages of the disease course of dementia: Two quasi-randomized studies;2024-08-23